Introduction:Basic information about CAS 120014-06-4|donepezil, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | donepezil |
|---|
| CAS Number | 120014-06-4 | Molecular Weight | 379.492 |
|---|
| Density | 1.1±0.1 g/cm3 | Boiling Point | 527.9±50.0 °C at 760 mmHg |
|---|
| Molecular Formula | C24H29NO3 | Melting Point | 207ºC |
|---|
| MSDS | / | Flash Point | 273.1±30.1 °C |
|---|
Names
| Name | donepezil |
|---|
| Synonym | More Synonyms |
|---|
donepezil BiologicalActivity
| Description | Donepezil(E 2020) is a specific and potent AChE inhibitor for bAChE and hAChE with IC50 of 8.12 nM and 11.6 nM, respectively.Target: AChEDonepezil is a specific and potent AChE inhibitor for bAChE and hAChE with IC50 of 8.12 nM and 11.6 nM , respectively [1]. Donepezil inhibits the carbachol-stimulated increase in intracellular Ca2+ concentration in human SHSY5Y neuroblastoma cells in a concentration dependent manner, indicating that Donepezil have muscarinic antagonist activity. Intraperitoneal administration of Donepezil in rats produces a dose dependent increase in salivation and tremor, which are overt cholinergic behavioural signs, with an ED50 of 6 μmol/kg. Donepezil is found to be somewhat less potent with a ED50 of 50 μmol/kg following oral administration [2]. A recent study shows that Donepezil can protect human umbilical vein endothelial cells (HUVECs) against H2O2-induced cell injury. This may be useful as a potential therapy for oxidative stress in cardiovascular and cerebrovascular diseases [3]. |
|---|
| Related Catalog | Signaling Pathways >>Neuronal Signaling >>AChEResearch Areas >>Neurological Disease |
|---|
| References | [1]. Ogura, H., et al., Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Methods Find Exp Clin Pharmacol, 2000. 22(8): p. 609-13. [2]. Snape, M.F., et al., A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066. Neuropharmacology, 1999. 38(1): p. 181-93. [3]. Huang, Z.H., et al., Donepezil protects endothelial cells against hydrogen peroxide-induced cell injury. CNS Neurosci Ther, 2012. 18(2): p. 185-7. |
|---|
Chemical & Physical Properties
| Density | 1.1±0.1 g/cm3 |
|---|
| Boiling Point | 527.9±50.0 °C at 760 mmHg |
|---|
| Melting Point | 207ºC |
|---|
| Molecular Formula | C24H29NO3 |
|---|
| Molecular Weight | 379.492 |
|---|
| Flash Point | 273.1±30.1 °C |
|---|
| Exact Mass | 379.214752 |
|---|
| PSA | 38.77000 |
|---|
| LogP | 4.71 |
|---|
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
|---|
| Index of Refraction | 1.578 |
|---|
| InChIKey | ADEBPBSSDYVVLD-UHFFFAOYSA-N |
|---|
| SMILES | COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 |
|---|
| Water Solubility | 2.931 mg/L |
|---|
Safety Information
| Hazard Codes | Xi: Irritant; |
|---|
| Risk Phrases | R36/37/38 |
|---|
| Safety Phrases | 26-36 |
|---|
| RIDADR | UN 2811 |
|---|
Synonyms
| 2-((1-Benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one |
| 2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one |
| 2,3-Dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one |
| 5,6-Dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-2,3-dihydro-1H-inden-1-one |
| n-1-one |
| 2-[(1-Benzyl-4-piperidyl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one |
| 1H-Inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]- |
| Aricept |
| Donepezil hydrochloride monohydrate |
| (±)-E-2020 |
| 2-[(1-Benzyl-4-piperidinyl)methyl]-5,6-dimethoxy-1-indanone |
| 2-[(1-Benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one |
| MFCD00912833 |
| donepezil |
| 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE |
| 5,6-Dimethoxy-2,3-dihydro-1H-inden-1-one |
| Donezepil |
| 2-[(1-Benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydro-1H-inden-1-on |
| Donepezil Base |